scispace - formally typeset
Journal ArticleDOI

Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women

Reads0
Chats0
TLDR
Histories of oral contraceptive use were reported by 116,686 women aged 25 to 42 years in the Nurses' Health Study II on a self-administered questionnaire accompanied by a color photo booklet of all OC preparations ever marketed in the US.
About
This article is published in Contraception.The article was published on 1997-12-01. It has received 99 citations till now. The article focuses on the topics: Telephone interview.

read more

Citations
More filters
Journal ArticleDOI

Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.

TL;DR: Early age atMenarche, oral contraceptive use, early age at menopause, surgical menophere, and postmenopausal use of hormones were each associated with an increased risk of SLE, and these associations may point to the mechanisms underlying the pathogenesis of Lupus erythematosus.
Journal ArticleDOI

Oral contraceptives and the risk of myocardial infarction

TL;DR: This nationwide, population-based, case–control study investigated the association between the use of oral contraceptives and the risk of myocardial infarction according to the type of progestagen included in third-generation and second-generation oral contraceptives, the dose of estrogen, and the presence or absence of prothrombotic mutations.
Journal ArticleDOI

A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata

TL;DR: In this article, the risk of uterine leiomyomata in relation to reproductive factors and oral contraceptive use was investigated in a cohort of female registered nurses from 14 states in the United States who completed mailed questionnaires in 1989, 1991 and 1993.
Journal ArticleDOI

Reproductive history and endometriosis among premenopausal women.

TL;DR: Hormonal and anatomical changes associated with menstruation and pregnancy may affect the rate of laparoscopically confirmed endometriosis within this cohort, and risk was greatest among nulliparous women with earlier age at menarche and shorter menstrual cycles.
Journal ArticleDOI

AMA drug evaluations.

William R. Barclay
- 20 Jun 1977 - 
TL;DR: The third edition of the AMA Drug Evaluations book (ADE ) has just been published and provides for the physician information on how to prescribe effective and safe agents for most clinical conditions.
References
More filters
Journal ArticleDOI

Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53.297 women with breast cancer and 100.239 women without breast cancer from 54 epidemiological studies

Eugenia E. Calle, +188 more
- 22 Jun 1996 - 
TL;DR: Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies as mentioned in this paper.
Journal ArticleDOI

Investigation of relation between use of oral contraceptives and thromboembolic disease.

M. P. Vessey, +1 more
- 27 Apr 1968 - 
TL;DR: To determine the relationship between use of oral contraceptives and thromboembolic disease 58 married women discharged from 19 hospitals near London with diagnosis of thrombolic diseases (ICD 463-466) without predispoition were interviewed.
Journal ArticleDOI

AMA Drug Evaluations

Richard S. Jacobs
- 17 Jun 1974 - 
TL;DR: Of all the sections of the book, this particular one would seemingly offer the greatest potential for educating the physician as to the possible merits of a AMA-DE, the author imparts the hope that pharmacology instructors will use the book in the course of their teaching responsibilities.
Journal ArticleDOI

A quantitative assessment of oral contraceptive use and risk of ovarian cancer.

TL;DR: A quantitative assessment of the association between oral contraceptive use and ovarian cancer using results from the published literature found a summary relative risk of 0.64 associated with ever–use of OC, indicating a 36% reduction in ovarian cancer risk.
Related Papers (5)